专利检索 ap:("Myeloid Therapeutics, Inc.") AND inv:"Thomas Etienne Prod’homme" 第 1 页

1.

发明公开
COMPOSITIONS AND METHODS FOR CONDITIONING PATIENTS FOR CELL THERAPY 审中-公开

公开(公告)号：US20240139241A1

公开(公告)日：2024-05-02

申请号：US18492345

申请日：2023-10-23

申请人： Myeloid Therapeutics, Inc.

发明人： Daniel GETTS , Bruce J. McCreedy, JR. , Michele Luise Gerber , Thomas Etienne Prod’homme

IPC分类号： A61K35/15 , A61K31/4995 , A61K31/675 , A61K31/7076 , A61K39/00 , A61P35/00 , C07K16/28

CPC分类号： A61K35/15 , A61K31/4995 , A61K31/675 , A61K31/7076 , A61K39/4614 , A61K39/464429 , A61P35/00 , C07K16/2896 , A61K2239/15 , A61K2239/21 , A61K2239/22 , A61K2239/48

摘要： Compositions and methods for therapeutic use of engineered myeloid cells are described. Methods for increasing therapeutic effectiveness of immune cells by use of an immune cell inhibitory agent prior to therapy is described. Effective use of myeloid cells in combination therapy is described.